One-Shot gene therapy tested for untreatable burning pain
Disease control
Recruiting now
This early-stage study is testing a new, one-time gene therapy called ST-503 for people with severe, untreatable nerve pain from small fiber neuropathy. The therapy aims to block pain signals at their source by delivering a modified gene directly into the spinal fluid. Researcher…
Phase: PHASE1, PHASE2 • Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC